“HIV Drug
/ Medicine Market: Global Demand Analysis & Opportunity Outlook 2023”
The global HIV drug / medicine market
is segmented into drug type such as generic drugs and branded drugs. Among
these segments, generic drugs segment is expected to witness considerable
demand during the forecast period. Generic drugs are way cheaper than branded
drugs and effective just as branded drugs. Further, low cost of generic drugs is
a key factor which is expected to fuel the growth of this segment during the
forecast period.
Global HIV drug / medicine market
is expected to register a 5.9% CAGR over the forecast period. Moreover, the global
HIV drug / medicine market was valued at USD 26.9 Billion in 2015 and is
expected to reach at notable revenue of around USD 38.1 Billion by the end of
2023. The market is expected to expand on the back of number of people living
with HIV across the globe and ongoing research & development activates to
develop more effective drugs. Additionally, the demand for generic HIV drugs is
expected to rise in future due to increasing number of people living with HIV
in low income nations.
The nucleoside reverse
transcriptase inhibitors segment by medication class is likely to grow at remarkable
pace during the forecast period. Moreover, effective results of nucleoside
reverse transcriptase inhibitors in prevention and controlling of HIV infection
is likely to drive the growth of this segment during the forecast period.
Rising Population
Suffering from HIV
According to world health organization, in 2016 around
36.7 Million people are living with HIV
globally. The demand
for HIV drugs is expected to rise in near future owing to large number
of population living with HIV across the globe. Furthermore, advancements in medical
science and huge spending on research and development activities on HIV drugs are
expected to escalate the growth of global HIV drug/Medicine market in near
future.
Favourable
Government Initiatives and Programs
Various initiatives by
Government of different countries to aware population regarding HIV infection
and their treatment are expected to fuel the demand for HIV drugs in near
future. In addition to this, governments are taking initiatives to provide HIV
drugs to the population suffering from HIV at very affordable price is a major
factor which is predicted to foster the growth of market.
Although, high cost of branded HIV
drug / medicine, lack of availability of better and effective cure for HIV in
low income countries are some of the factors that are likely to inhibit the
growth of the HIV drug / medicine market in the near future.
The
report titled “HIV Drug
/ Medicine Market : Global Demand Analysis & Opportunity Outlook 2023” delivers detailed overview of
the global HIV drug / medicine market in terms of market segmentation by drug
type, by medication class and by region.
Further,
for the in-depth analysis, the report encompasses the industry growth drivers,
restraints, supply and demand risk, market attractiveness, BPS analysis and
Porter’s five force model.
This report also provides the
existing competitive scenario of some of the key players of the global HIV drug
/ medicine market which includes company profiling of GlaxoSmithKline PLC., Merck & Co., Inc., Johnson and Johnson, Hetero
Drugs Limited, Gilead Sciences, Cipla Limited, Abbott Laboratories, Pfizer Inc.,
ViiV Healthcare and Macleods Pharmaceuticals Ltd. The profiling enfolds
key information of the companies which encompasses business overview, products
and services, key financials and recent news and developments. On the whole,
the report depicts detailed overview of the global HIV drug / medicine market
that will help industry consultants, equipment manufacturers, existing players
searching for expansion opportunities, new players searching possibilities and
other stakeholders to align their market centric strategies according to the
ongoing and expected trends in the future.
About Research
Nester
Research Nester is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision so as to avoid future uncertainties.
Read more Information: http://bit.ly/2zHlE63
Contact for more
Info:
Ajay
Daniel
U.S.
+1 646 586 9123
U.K.
+44 203 608 5919
No comments:
Post a Comment